Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value
$662.35M
Total Bought
$0
Total Sold
$4.74M
Net Transaction
-$4.74M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620134,016213,68232.26%+79,665
Vigil Neuroscience, Inc.5,836,8745,836,874010,39046,4037.01%+36,014
Sionna Therapeutics, Inc.(SION)3,694,0203,694,020038,63964,0919.68%+25,452
Third Harmonic Bio, Inc.10,402,28610,402,286036,09656,4848.53%+20,388
Disc Medicine, Inc.(IRON)2,384,4562,384,4560118,364126,28119.07%+7,916
Ikena Oncology, Inc.5,018,1785,018,17806,4236,7241.02%+301
Spero Therapeutics, Inc.(SPRO)305,2550-305,2552200—-220
Q32 Bio, Inc.(FIXX)2,092,1062,092,10603,4523,1170.47%-335
Generation Bio, Co.8,279,4848,279,48403,3532,6500.40%-703
Aerovate Therapeutics, Inc.1,799,2320-1,799,2324,5160—-4,516
Korro Bio, Inc.(KRRO)1,137,1491,137,149019,79814,2032.14%-5,595
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,465095,50586,92213.12%-8,583
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,257050,99241,7976.31%-9,195
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q2 2025 | TickerTrail